Skip to main content
. 2014 Dec;66(Suppl 3):S1–S51. doi: 10.1016/j.ihj.2014.12.001

Table 15.

The management of dyslipidemia in adults with chronic kidney disease.

Dyslipidemia Goal Initiate Increase Alternative
TG ≥ 500 mg/dl TG < 500 mg/dl Lifestyle changes Lifestyle changes + fibrate or niacin Fibrate or niacin
LDL-C 100–129 mg/dl LDL-C < 100 mg/dl Lifestyle changes Lifestyle changes + low-dose statin Bile acid sequestrant or niacin
LDL-C ≥ 130 mg/dl LDL-C < 100 mg/dl Lifestyle changes + low-dose statin Lifestyle changes + max-dose statin Bile acid sequestrant or niacin
TG ≥ 200 mg/dl and non-HDL-C ≥ 130 mg/dl Non-HDL-C < 130 mg/dl Lifestyle changes + low-dose statin Lifestyle changes + max-dose statin Fibrate or niacin